Clinical Study
Value of C-Reactive Protein in Predicting Left Ventricular Remodelling in Patients with a First ST-Segment Elevation Myocardial Infarction
Table 1
Demographic and clinical characteristics of the study population.
| | Variable | Overall study population () | Patients with LVR () | Patients without LVR () | for comparison between groups with and without LVR |
| | Age (years) | 56.0 (50.0–64.0) | 54.0 (49.0–63.0) | 57.0 (51.0–64.0) | NS | | Gender (male/female) (%) | 153/45 (77.3/22.7) | 46/9 (83.6/16.4) | 107/36 (74.8/25.2) | NS | | Anterior location of STEMI (%) | 89 (43.6) | 30 (54.6) | 58 (40.6) | NS | | Time from onset of pain to balloon inflation (minutes) | 201.5 (141.0–295.0) | 207.0 (135.0–308.0) | 200.0 (145.0–295.0) | NS |
| | Risk factors for coronary artery disease |
| | Body mass index (kg/m2) | 26.8 (24.2–29.1) | 27.5 (24.8–30.4) | 26.2 (24.1–28.8) | NS | | Hypertension (%) | 82 (41.4) | 27 (49.1) | 55 (38.5) | NS | | Diabetes mellitus (%) | 40 (20.2) | 13 (23.6) | 27 (18.9) | NS | | Current or ex-smoker (%) | 131 (66.2) | 34 (61.8) | 97 (67.8) | NS |
| | Medical treatment at hospital discharge |
| | Long-acting metoprolol (%) | 196 (99.0) | 55 (100.0) | 141 (98.6) | NS | | Perindopril (%) | 194 (98.0) | 53 (96.4) | 141 (98.6) | NS | | Simvastatin (%) | 197 (99.5) | 55 (100.0) | 142 (99.3) | NS | | Spironolactone (%) | 12 (6.1) | 5 (9.1) | 7 (4.9) | NS | | Nonpotassium-sparing diuretics (%) | 11 (5.6) | 4 (7.3) | 7 (4.9) | NS |
|
|
LVR: left ventricular remodelling; STEMI: ST-segment elevation myocardial infarction.
|
